ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ACIN1 | Apoptotic chromatin condensation inducer 1 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO6 | Anoctamin 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ANXA2 | Annexin A2 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ANXA6 | Annexin A6 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ASNA1 | ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide | CD markers Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP4B | ATPase, H+/K+ exchanging, beta polypeptide | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1C1 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1F | ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Predicted intracellular proteins Transporters
| | | | | Tissue enriched |